Protein Biomarkers and Risk of Atrial Fibrillation

Relation of IGF-1 and IGFBP-3 with prevalent and incident atrial fibrillation in a population-based study

(2019) Mathias Busch et al.   HEART RHYTHM

Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction

(2018) Camilla Hage et al.   AMERICAN JOURNAL OF CARDIOLOGY

Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status

(2018) Liping Mou et al.   Circulation-Arrhythmia and Electrophysiology

Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study

(2018) Laila Staerk et al.   BMJ-British Medical Journal

Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study

(2018) Laila Staerk et al.   BMJ-British Medical Journal

Protein Biomarkers of Cardiovascular Disease and Mortality in the Community

(2018) Jennifer E. Ho et al.   Journal of the American Heart Association

Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation

(2018) Winnie Chua et al.   EUROPEAN HEART JOURNAL

Impact of atrial fibrillation on platelet gene expression

(2017) Waldemar E. Wysokinski et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke

(2017) Hamidreza Saber et al.   STROKE

Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation

(2017) Lu-Chen Weng et al.   CIRCULATION

Interaction between fibrinogen and insulin-like growth factor-binding protein-1 in human plasma under physiological conditions

(2016) N. Gligorijević et al.   BIOCHEMISTRY-MOSCOW

Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip

(2016) Lars Lind et al.   HEART

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis

(2016) Ayodele Odutayo et al.   BMJ-British Medical Journal

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis

(2016) Ayodele Odutayo et al.   BMJ-British Medical Journal

Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase

(2015) Sergiy Sukhanov et al.   ATHEROSCLEROSIS

50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study

(2015) Renate B Schnabel et al.   LANCET

Protein Biomarkers of New-Onset Cardiovascular Disease

(2014) Xiaoyan Yin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies

(2014) Moritz F. Sinner et al.   EUROPACE

The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice

(2014) Geeta Sapra et al.   Nature Communications

Relation between soluble ST2, growth differentiation factor–15, and high-sensitivity troponin I and incident atrial fibrillation

(2013) Michiel Rienstra et al.   AMERICAN HEART JOURNAL

Insulin-Like Growth Factor I, Insulin-like Growth factor Binding Protein 3, and Atrial Fibrillation in the Elderly

(2013) E. Duron et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Simple Risk Model Predicts Incidence of Atrial Fibrillation in a Racially and Geographically Diverse Population: the CHARGE‐AF Consortium

(2013) Alvaro Alonso et al.   Journal of the American Heart Association

Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease

(2012) Dao-Fu Dai et al.   ANTIOXIDANTS & REDOX SIGNALING

Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effects

(2011) Sergiy Sukhanov et al.   FEBS LETTERS

Circulating levels of insulin-like growth factor binding protein–1 in relation to insulin resistance, type 2 diabetes mellitus, and metabolic syndrome (Chennai Urban Rural Epidemiology Study 118)

(2011) Kuppan Gokulakrishnan et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Growth Factor-Induced Mobilization of Cardiac Progenitor Cells Reduces the Risk of Arrhythmias, in a Rat Model of Chronic Myocardial Infarction

(2011) Leonardo Bocchi et al.   PLoS One

Circulating Insulin-Like Growth Factor-1 and Its Binding Protein-3

(2010) Carolyn S.P. Lam et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the Community

(2010) Renate B. Schnabel et al.   CIRCULATION

IGF-1, oxidative stress and atheroprotection

(2010) Yusuke Higashi et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome?

(2009) Wenjing Ruan et al.   ACTA DIABETOLOGICA

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

(2009) Renate B Schnabel et al.   LANCET